From the Editor-in-Chief
Altering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
What Is CRISPR? | Longer Treatment May Benefit Some Breast Cancer Patients | Addressing Depression in Adult Cancer Survivors | The Impact of Rising Drug Costs | Report Links Excess Weight to Eight More Cancer Types | Little Consensus on Ovarian Cancer Monitoring | No Link Found Between IVF and Breast Cancer Risk | World Cancer Day: Accelerating Progress
Your Cancer Guide
A cancer diagnosis can prompt survivors to question or deepen their faith.
by Hester Hill Schnipper
Caregiving With Confidence
Take these steps to delegate responsibilities and strike a balance.
by Liz Seegert
A breast cancer survivor recounts how she became a resource for others.
by Cynthia Ryan
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
Oncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.
by Stephen Ornes
A cancer survivor embarks on a spiritual journey to Poland and finds inspiration in a local cancer hospital.
Reaping Grains' Benefits | Put a Cork in It
Cancer survivor Ann Ogden Gaffney left her job in fashion to teach other cancer survivors how to cook.
Coping with a difficult parent, sexual activity during treatment, and talking with children about inheritable cancers.
A diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
Darla Moore, Janiela Roachford, Roseanne Venturino.
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves an antihormone agent to treat prostate cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR